EPO and myeloproliferative disorder: Additional testing, including PCR or FISH techniques for bcr-abl, JAK-2 mutational testing, erythropoietin levels, and bone marrow examination with cytogenetics, must be warranted for patients suspected of having a myeloproliferative neoplasm [3].